Skip to content

Effects on Glycemia and Insulinemia of Different Grape Varieties

Assessment of the Effect of Different Varieties of Grapes on Postprandial Glycemia and Insulinemia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06748430
Acronym
SUGARGAP
Enrollment
20
Registered
2024-12-27
Start date
2024-06-25
Completion date
2024-11-29
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycaemic Response Measurements, Healthy

Keywords

Grape variety, Glycaemic response, metabolome, insulin response

Brief summary

The goal of this intervention study is to examine the glucose increase in blood, during 2 hours after consuming different varieties of grapes, in men and women with normal or excess body weight. The main question it aims to answer is: can a variety of red grape reduce the glucose curve compared to a reference variety? Participants will have to attend the Center for nutrition research facilities in three occasions, fasted for at least 8 hours. Once there, they will be measured and monitored. A canula will be inserted and once they finish eating 300g of grapes, blood extractions will be performed at minutes 15, 30, 60, 90 and 120.

Detailed description

The main purpose of this study is to evaluate how the glucose and insulin curves develop after consuming different grapes varieties. Still, we also want to evaluate how the serum metabolome changes with the three varieties after 120 minutes. Therefore, a metabolomic study will be done in samples of volunteers at this time point. The intervention is longitudinal and in three arms (one per variety). Due to the harvest of the different varieties, it cannot be crossover, but each subject will consume the three varieties. At each visit, the subjects will undergo the same schedule: * Arrival in a fasting state of at least 8 hours. * Insertion of cannula and extraction of fasting samples * Consumption of approximately 300 g of grapes (50 g of Carbohydrates). * Extraction of blood samples at 15, 30, 60, 90 and 120 minutes.

Interventions

OTHERGrape variety control

Reference grape variety

OTHERGrape variety 1

First grape variety to evaluate

OTHERGrape variety 2

Second grape variety to evaluate

Sponsors

Clinica Universidad de Navarra, Universidad de Navarra
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

The group of subjects will go through the three visits of the study in the same order. All subjects will consume the same variety at the same time.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Baseline glycaemia between 70 and 100 mg/dL * BMI between 18.5 kg/m2 and 29.9 kg/m2. * Absence of disease or alterations related to gastrointestinal status. * Signed written informed consent.

Exclusion criteria

* Glycaemic levels out of the reference inclusion criteria (below 70 or over 100 mg/dL) * Subjects presenting BMI out of the limits set. * Subjects with unstable body weight the three months prior the start of the study (+/- 3 Kg) * Subjects not able to attend the preestablished visits * Women pregnant or lactating * Subjects undergoing pharmacological treatment

Design outcomes

Primary

MeasureTime frameDescription
Glycaemic response0 minutesAssessment of serum glucose evolution after consuming 50 g of carbohydrates in grapes
Insulinemic response0 minutesAssessment of serum insulin evolution after consuming 50 g of carbohydrates in grapes
Insulin Resistance Index (HOMA-IR) response0 minutesAssessment of insulin resistance evolution after consuming 50 g of carbohydrates in grapes
Metabolome composition120 minutesMetabolomic analysis after grapes consumption

Secondary

MeasureTime frameDescription
ALT0 minutesSerum ALT levels in fasting state
Total cholesterol0 minutesSerum total cholesterol in fasting state
AST0 minutesSerum AST levels in fasting state
LDL - cholesterol0 minutesSerum LDL-cholesterol in fasting state
HDL-cholesterol0 minutesSerum HDL-cholesterol in fasting state
Triglycerides0 minutesSerum triglycerides in the fasting state

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026